These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19682599)

  • 1. Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity.
    Heuts F; Carow B; Wigzell H; Rottenberg ME
    Microbes Infect; 2009 Dec; 11(14-15):1114-21. PubMed ID: 19682599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice.
    Hickey MJ; Arain TM; Shawar RM; Humble DJ; Langhorne MH; Morgenroth JN; Stover CK
    Antimicrob Agents Chemother; 1996 Feb; 40(2):400-7. PubMed ID: 8834887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
    Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
    PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary isoniazid resistance in Mycobacterium bovis disease: a prospect of concern.
    McLaughlin AM; Gibbons N; Fitzgibbon M; Power JT; Foley SC; Hayes JP; Rogers T; Keane J
    Am J Respir Crit Care Med; 2012 Jul; 186(1):110-1. PubMed ID: 22753693
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.
    Moreira AL; Tsenova L; Murray PJ; Freeman S; Bergtold A; Chiriboga L; Kaplan G
    Microb Pathog; 2000 Sep; 29(3):175-85. PubMed ID: 10968949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative spondylodiscitis caused by Mycobacterium bovis BCG: a case study.
    Rätsep T
    Spine J; 2012 Dec; 12(12):e1-5. PubMed ID: 23182026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase.
    Andreu N; Zelmer A; Sampson SL; Ikeh M; Bancroft GJ; Schaible UE; Wiles S; Robertson BD
    J Antimicrob Chemother; 2013 Sep; 68(9):2118-27. PubMed ID: 23633686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice.
    Guirado E; Amat I; Gil O; Díaz J; Arcos V; Caceres N; Ausina V; Cardona PJ
    Microbes Infect; 2006 Apr; 8(5):1252-9. PubMed ID: 16702016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene chip array for differentiation of mycobacterial species and detection of drug resistance.
    Shi XC; Liu XQ; Xie XL; Xu YC; Zhao ZX
    Chin Med J (Engl); 2012 Sep; 125(18):3292-7. PubMed ID: 22964326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of antitubercular therapy with IFNγ in a patient with dominant partial IFNγ receptor 1 deficiency.
    Takeda K; Kawai T; Nakazawa Y; Komuro H; Shoji K; Morita K; Katsuta T; Yamamoto M; Miyairi I; Ohya Y; Ishiguro A; Onodera M
    Clin Immunol; 2014 Mar; 151(1):25-8. PubMed ID: 24509072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirteen years of culture-positive M. bovis-BCG infection in an IL-12Rbeta1 deficient patient: treatment and outcome.
    Rosenzweig SD; Yancoski J; Bernasconi A; Krasovec S; Marciano BE; Casimir L; Berberian G; Símboli N; Rousseau M; Calle G
    J Infect; 2006 Mar; 52(3):e69-72. PubMed ID: 16181679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of susceptibility of Mycobacterium bovis to antituberculous drugs by radiometric BACTEC 460TB system.
    Cavirani S; Fanti F; Benecchi M; Calderaro A; Taddei S; Arcangeletti C; Medici MC; Dettori G; Chezzi C
    New Microbiol; 2003 Apr; 26(2):181-6. PubMed ID: 12737201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antimycobacterial response to recombinant Mycobacterium bovis BCG expressing latency-associated peptide.
    Marshall BG; Wangoo A; O'Gaora P; Cook HT; Shaw RJ; Young DB
    Infect Immun; 2001 Nov; 69(11):6676-82. PubMed ID: 11598037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
    Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.